← Back to the catalog
DossierIn-vitro validated

Senescence-program selective reverser — target-engagement confirmed

Computational selective-reversal signal confirmed in a target-engagement assay panel (mechanism-level; not an efficacy or disease endpoint).

Research intelligence — a ranked, filtered hypothesis, not a validated cure. No disease or efficacy claim. Computational transcriptomic prediction, pending wet-lab.

Mechanism
Selective reversal of a cellular-senescence gene-expression program
Validation state
In-vitro validated — Mechanism-level signal confirmed in an in-vitro assay panel. Not an efficacy or disease endpoint.
Tox gate
Clean (Brenk/PAINS/NIH + cytotox + carcinogen blocklist)
Trial whitespace
Deprioritized — not virgin — Prior trials exist but the asset was shelved — not virgin whitespace. Listed with the why-untried qualifier (graveyard check).
IP class
Known drug — Approved/clinical compound. Intelligence only — no compound IP conveyed.
Headline

Validation-state demonstration · in-vitro target-engagement confirmed · still pending efficacy

In-vitro validated· 2026-06-02
Related listings

Same mechanism or overlapping tags. Computational, pending wet-lab.

Mitochondrial-function induction (SDHB / SIRT3 / NRF2 / HSPD1 / DLD / ANT1 / TOMM34)
Selective mitochondrial-function inducers — clinically untried
~5,000 LINCS compounds scored · top selective mito-inducers, cytotox-gated
Selective reversal of an aging (GSE107037) gene-expression program
Caffeic-acid phenethyl ester (CAPE) — aging-program reverser dossier
Propolis-derived NP · selective aging-program reverser · DSHEA structure-function candidate
Full intelligence is gated

Unlock the full dossier on the Exchange.

The full dossier — ranked candidate lists, measured-selectivity detail, published-literature corroboration, and known-compound structures — is delivered as a PDF to your checkout email. The teaser and the free academic package above are always public.

Buy this dossier →

Provenance: Illustrative placeholder (schema demonstration). NOT a measured result — the validation layer is not yet built. See EXCHANGE_README.md. · Updated 2026-06-02.
Research intelligence, not medical, efficacy, or freedom-to-operate advice. All candidate signals are computational transcriptomic predictions pending wet-lab validation. The subscriber owns development and claims decisions and is responsible for its own freedom-to-operate. CONFIDENTIAL — MightyCloud Collective / OmniRayn Foundry.